World Wires · Story 68223 · corroborated · 1 Quelle(n)

Development of CYP8B1-specific inhibitors for metabolic diseases

Changes in bile acids (BAs) balance lead to various metabolic diseases, yet current treatment options targeting these changes remain severely limited. CYP8

Im Desk öffnen

Berichterstattung

Was diese Seite indexiert